Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-α and IL-8 secretion by a CD14-Toll-like receptor 2-dependent mechanism

Journal of Immunology

Volumn 171, Issue 4, 2003, Pages 2014-2023

  Vignal, Cécile ^a   Guérardel, Yann ^a   Kremer, Laurent ^b   Masson, Maryse ^a   Legrand, Dominique ^a   Mazurier, Joël ^a   Elass, Elisabeth ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARABINAN; CD14 ANTIGEN; GLYCOLIPID; INTERLEUKIN 8; LIPOARABINOMANNAN; LIPOMANNAN; LIPOPOLYSACCHARIDE BINDING PROTEIN; MANNAN; MANNOSE; PHOSPHATIDYLINOSITOL DIMANNOSIDE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM KANSASII; PRIORITY JOURNAL; SPECIES DIFFERENCE;

EID: 0041633850     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.4.2014     Document Type: Article

References (63)

1. Daffe, M., and P. Draper. 1998. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 39:131.
2. Chatterjee, D. 1997. The mycobacterial cell wall: structure, biosynthesis and sites of drug action. Curr. Opin. Chem. Biol. 1:579.
3. Chatterjee, D., and K. H. Khoo, 1998. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8-113.
4. Nigou, J., M. Gilleron, M. Rojas, L. F. Garcia, M. Thurnher, and G. Puzo. 2002. Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response. Microbes Infect. 4:945.
5. Chatterjee, D., A. D. Roberts, K. Lowell, P. J. Brennan, and I. M. Orme. 1992. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect. Immun. 60:1249.
6. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan: relationship to chemical structure. J. Immunol. 149:541.
7. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Invest. 91:2076.
8. Zhang, Y., M. Broser, H. Cohen, M. Bodkin, K. Law. J. Reibman, and W. N. Rom. 1995. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 95:586.
9. Yoshida, A., and Y. Koide. 1997. Arabinofuranosyl-terminated and mannosylated lipoarabinomannans from Mycobacterium tuberculosis induce different levels of interleukin-12 expression in murine macrophages. Infect. Immun. 65:1953.
10. Nigou, J., C. Zelle-Rieser, M. Gilleron, M. Thurnher, and G. Puzo. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cell: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166:7477.
11. Sibley, L. D., S. W. Hunter, P. J. Brennan, and J. L. Krahenbuhl. 1988. Mycobacterial lipoarabinomannan inhibits γ-interferon-mediated activation of macrophages. Infect. Immun. 56:1232.
12. Moreno, C., A. Mehlert, and J. Lamb. 1988. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin. Exp. Immunol. 74:206.
13. Chatterjee, D., K. Lowell, B. Rivoire, M. R. McNeil, and P. J. Brennan. 1992. Lipoarabinomannan of Mycobacterium tuberculosis: capping with mannosyl residues in some strains. J. Biol. Chem. 267:6234.
14. Khoo, K. H., A. Dell, H. R. Morris, P. J. Brennan, and D. Chatterjee. 1995. Inositol phosphate capping of the nonreducing temini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem. 270:12380.
15. Hunter, S. W., and P. J. Brennan. 1990. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J. Biol. Chem. 265:9272.
16. Venisse, A., J. M. Berjeaud, P. Chaurand, M. Gilleron, and G. Puzo. 1993. Structural features of lipoarabinomannan from Mycobacterium bovis BCG: determination of a molecular mass by laser desorption mass spectrometry. J. Biol. Chem. 268:12401.
17. Khoo, K. H., A. Dell, H. R. Morris, P. J. Brennan, and D. Chatterjee. 1995. Structural definition of acylated phosphatidylinositol mannosides from Mycobacterium tuberculosis: definition of a common anchor for lipomannan and lipoarabinomannan. Glycobiology 5:117.
18. Gilleron, M., N. Himoudi, O. Adam, P. Constant, A. Venisse, M. Riviere, and G. Puzo. 1997. Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans: structure and localization of alkali-labile and alkali-stable phosphoinositides. J. Biol. Chem. 272:117.
19. Khoo, K. H., J. B. Tang, and D. Chatterjee. 2001. Variation in mannose-capped terminal arabinan motifs of lipoarabinomannans from clinical isolates of Mycobacterium tuberculosis and Mycobacterium avium complex. J. Biol. Chem. 276:3863.
20. Takeuchi, O., and S. Akira. 2001. Toll-like receptors: their physiological role and signal transduction system. Immunopharmacol. 1:625.
21. Heldwein, K. A., and M. J. Fenton. 2002. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect. 4:937.
22. Lien, E., and R. R. Ingalls. 2002. Toll-like receptors. Crit. Care Med. 30:S1.
23. Underhill, D. M., and A. Ozinsky. 2002. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 14:103.
24. Underhill, D. M., A. Ozinsky, K. D. Smith, and A. Aderem. 1999. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96:14459.
25. 1-152 confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J. Immunol. 161:4244.
26. Means, T. K., E. Lien, A. Yoshimura, S. Wang, D. T. Golenbock, and M. J. Fenton. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163:6748.
27. Savedra, R., R. L. Delude, R. R. Ingalls, M. J. Fenton, and D. T. Golenbock. 1996. Mycobacterial lipoarabinomannan recognition requires a receptor that shares components of the endotoxin signaling system. J. Immunol. 157:2549.
28. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchenko. Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509.
29. Fenton, M. J., and D. T. Golenbock. 1998. LPS-binding proteins and receptors. J. Leukocyte Biol. 64:25.
30. Wright, S. D., R. A. Ramos. P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431.
31. Venisse, A., J. J. Fournie, and G. Puzo. 1995. Mannosylated lipoarabinomannan interacts with phagocytes. Eur. J. Biochem. 231:440.
32. Knutson, K. L., Z. Hmama, P. Herrera-Velit, R. Rochford, and N. E. Reiner. 1998. Lipoarabinomannan of Mycobacterium tuberculosis promotes protein tyrosine dephosphorylation and inhibition of mitogen-activated protein kinase in human mononuclear phagocytes: role of the Src homology 2 containing tyrosine phosphatase. J. Biol. Chem. 273:645.
33. Maeda, N., J. Nigou, J. L. Herrmann, M. Jackson, A. Amara, P. H. Lagrange, G. Puzo, B. Gicquel, and O. Neyrolles. 2003. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 278:5513.
34. Geijtenbeek, T. B. H., S. J. van Vliet, E. A. Koppel, M. Sanchez-Hernandez, C. M. J. E. Vandenbroucke-Grauls, B. Appelmelk, and Y. van Kooyk. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:7.
35. Rafael, E., and E. Carlos. 1997. Mycobacterium kansasii disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24:1233.
36. Pintado, V., E. Gomez-Mampaso, P. Martin-Davila, J. Cobo, E. Navas, C. Quereda, J. Fortun, and A. Guerrrero. 1999. Mycobacterium kansasii infection in patients infected with human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 18:582.
37. Jacobson, K. L., R. Teira, H. I. Libshitz, I. Raad, K. V. I. Rolston, J. Tarrand, and E. Whimbey. 2000. Mycobacterium kansasii infections in patients with cancer. Clin. Infect. Dis. 30:965.
38. Wallace, R. J., Jr., B. A. Brown, and G. O. Onyi. 1992. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J. Infect Dis. 166:405.
39. Ingram, C. W., D. C. Tanner, D. T. Durack, G. W. Kernodle, Jr., and G. R. Corey. 1993. Disseminated infection with rapidly growing mycobacteria. Clin. Infect. Dis. 16:463.
40. Guérardel, Y., E. Maes, E. Elass, Y. Leroy, P. Timmerman, G. S. Besra, C. Locht, G. Strecker, and L. Kremer. 2002. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae: presence of unusual components with α1.3-mannopyranose side chain. J. Biol. Chem. 277:30635.
41. Nigou, J., M. Gilleron, B. Cahuzac, J. D. Bounéry, M. Herold, M. Thumher, and G. Puzo. 1997. The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette-Guérin: heterogeneity, structure and role in the regulation of cytokine production. J. Biol. Chem. 272:23094.
42. Gilleron, M., L. Bala, T. Brando, A. Vercellone, and G. Puzo. 2000. Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans: characterization of the acyl- and glyco-forms. J. Biol. Chem. 275:677.
43. Treumann A., F. Xidong, L. McDonnell, P. J. Derrick, A. E. Ashcroft, D. Chatterjee, and S. W. Homans. 2002. 5-Methylthiopentose: a new substituent on lipoarabinomannan in Mycobacterium tuberculosis. J. Mol. Biol. 316:89.
44. Ludwiczak P., M. Gilleron, Y. Bordat, C. Martin, B. Gicquel, and G. Puzo. 2002. Mycobacterium tuberculosis phoP mutant: lipoarabinomannan molecular structure. Microbiology 148:3029.
45. 3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J. Immunol. 149:2040.
46. Stokes, D. C., J. L. Shenep, M. Fishman, W. K. Hildner, G. K. Bysani, and K. Rufus. 1989. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-α from alveolar macrophages. J. Infect. Dis. 160:52.
47. Friedland, J. S., D. G. Remick, R. Shattock, and G. E. Griffin. 1992. Secretion of interleukin-8 following phagocytosis of Mycobacterium tuberculosis by human monocyte cell lines. Eur. J. Immunol. 22:1373.
48. Orr, S. L., and P. Tobias. 2000, LPS and LAM activation of the U373 astrocytoma cell line: differential requirement for CD14. J. Endotoxin Res. 6:215.
49. Stelter, F., M. Bernheiden, R. Menzel, R. S. Jack, S. Witt, X. Fan, M. Pfister, and C. Schütt. 1997. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur. J. Biochem. 243:100.
50. Landmann, R., B. Muller, and W. Zimmerli. 2000. CD14, new aspects of ligand and signal diversity. Microbes Infect. 2:295.
51. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419.
52. Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97:13766.
53. Abel, B., N. Thieblemont, V. J. F. Quesniaux, N. Brown, J. Mpagi, K. Miyake, F. Bihl, and B. Ryffel. 2002. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J. Immunol. 169:3155.
54. Tobias, P. S., J. C. Mathison, and R. J. Ulevitch. 1988. A family of lipopolysaccharide binding proteins involved in responses to Gram-negative sepsis. J. Biol. Chem. 263:13479.
55. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429.
56. Juffermans, N. P., A. Verbon, S. J. H. van Deventer, W. A. Buurman, H. van Deutekom, P. Speelman, and T. Van Der Poll. 1998. Serum concentration of lipopolysaccharide activity-modulating proteins during tuberculosis. J. Infect. Dis. 178:1839.
57. Sidobre, S., G. Puzo, and M. Rivière. 2002. Lipid-restricted recognition of mycobacterial lipoglycans by human pulmonary surfactant protein A: a surface-plasmon-resonance study. Biochem. J. 365:89.
58. Bovin, N. V. 1997. Carbohydrate-carbohydrate interaction. In Glycoscience: Status and Perspective. H. J. Gabius and S. Gabius, eds. Chapman & Hall, Weinheim, Germany, p. 277.
59. Jones, B. W., T. K. Means, K. A. Heldwein, M. A. Keen, P. J. Hill, J. T. Belisle, and M. J. Fenton. 2001. Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukocyte Biol. 69:1036.
60. Roach, T. I., C. H. Barton, D. Chatterjee, and J. M. Blackwell. 1993. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-α. J. Immunol. 150:1886.
61. Adams, L. B., Y. Fukutomi, and J. L. Krahenbuhl. 1993. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect. Immun. 61:4173.
62. Geijtenbeek, T. B. H., R. Torensma, S. J. Van Vliet, G. C. F. Van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575.
63. Guérardel, Y., E. Maes, V. Briken, F. Chirat, Y. Leroy, C. Locht, G. Strecker, and L. Kremer. Lipomannan and lipoarabinomannan from a clinical isolate of Mycobacterium kansasii: novel structural features and apoptosis-inducing properties. J. Biol. Chem. In press.